AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.64
-0.68 (-6.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AgomAb Therapeutics NV Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
| Net Income | -62.55 | -46.27 | -11.39 | -8.14 | - | |
| Depreciation & Amortization | 0.22 | 0.31 | 0.1 | 0.02 | - | |
| Stock-Based Compensation | 5.36 | 1.07 | 2.16 | 2.21 | - | |
| Other Operating Activities | 4.83 | -0.66 | -19.58 | -14.47 | - | |
| Change in Accounts Payable | 2.36 | -0.23 | 3.69 | 2.95 | - | |
| Change in Unearned Revenue | 0.75 | -0.4 | -0.58 | 1.45 | - | |
| Change in Other Net Operating Assets | -2.7 | -0.66 | 1.01 | -2.99 | - | |
| Operating Cash Flow | -51.74 | -46.83 | -24.59 | -18.97 | - | |
| Capital Expenditures | -0 | -0.68 | - | - | - | |
| Cash Acquisitions | -3 | - | - | -4.59 | - | |
| Investment in Securities | -30 | - | 40 | -40 | - | |
| Investing Cash Flow | -33 | -0.68 | 40 | -44.59 | - | |
| Long-Term Debt Issued | - | - | - | 0.14 | - | |
| Long-Term Debt Repaid | -0.34 | -0.16 | -0.1 | -0.72 | - | |
| Net Debt Issued (Repaid) | -0.34 | -0.16 | -0.1 | -0.58 | - | |
| Issuance of Common Stock | - | 97.06 | 79.87 | 38.39 | - | |
| Other Financing Activities | - | -0.13 | -0.45 | -0.17 | - | |
| Financing Cash Flow | -0.34 | 96.76 | 79.32 | 37.63 | - | |
| Foreign Exchange Rate Adjustments | 0.05 | -0.2 | - | - | - | |
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | |
| Net Cash Flow | -85.04 | 49.06 | 94.73 | -25.92 | - | |
| Free Cash Flow | -51.75 | -47.5 | -24.59 | -18.97 | - | |
| Free Cash Flow Per Share | -95.63 | -1900.12 | -983.68 | -758.68 | - | |
| Cash Interest Paid | - | 0.01 | 0.02 | 0.04 | - | |
| Cash Income Tax Paid | - | 0 | 0 | 0 | - | |
| Levered Free Cash Flow | -29.77 | -16.51 | -49.9 | - | - | |
| Unlevered Free Cash Flow | -29.68 | -16.47 | -49.88 | - | - | |
| Change in Working Capital | 0.41 | -1.28 | 4.12 | 1.41 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.